- •SCORE with age adjustment overestimates cardiovascular risk in RA patients.
- •SAF measurement yields similar results compared to the SCORE without age adjustment.
- •SCORE with no age adjustment combined with SAF might be the best strategy for RA.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.Arthritis Rheum. 2008; 59: 1690-1697
- On behalf of a trans-Atlantic cardiovascular consortium for rheumatoid arthritis (ATACC-RA). Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.Ann Rheum Dis. 2018; 77: 48-54https://doi.org/10.1136/annrheumdis-2017-211735
- British Society for Rheumatology Biologics Register Control Centre Consortium, British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology biologics register.Arthritis Rheum. 2007; 56: 2905-2912
- Dutch General Practitioner society (NHG) Multidisciplinary guideline on cardiovascular risk management.https://www.nhg.org/?q=standaarden/volledig/cardiovasculair-risicomanagementDate: 2011Date accessed: August 30, 2018
- European guidelines on CVD practices in clinical practice (2012).Eur Heart. 2012; 33: 1635-1701
- Simple non-invasive assessment of advanced glycation endproduct accumulation.Diabetologia. 2004; 47: 1324-1330
- Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.Diabetol Metab Syndr. 2017; 9: 42
- Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.Diabetologia. 2019 Feb; 62 ([Epub 2018 Nov]): 269-280https://doi.org/10.1007/s00125-018-4769-x